SIGA Technologies (NASDAQ:SIGA) announced Thursday that Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) approved its antiviral product Tepoxx (tecovirimat) for the treatment of ...

TEPOXX is the first antiviral therapy approved by the Pharmaceuticals and Medical Devices Agency (PMDA), in collaboration with the Japan Ministry of Health, Labour and Welfare, for the treatment ...

The FDA accepted applications for a golimumab biosimilar, while Samsung Biologics reported record sales, and a Japanese ...

Japan PM Ishiba's Approval Rate Rises 5 Points to 44%, NHK Poll Shows TOKYO (Reuters) - Japanese Prime Minister Shigeru Ishiba's cabinet approval rate rose 5 points from the previous month to 44% ...

TEPOXX is the first antiviral therapy approved by the Pharmaceuticals and Medical Devices Agency (PMDA), in collaboration with the Japan Ministry of Health, Labour and Welfare, for the treatment of ...